Reuters logo
BRIEF-Myriad will seek Japanese regulatory approval for Bracanalysis CDX
November 7, 2016 / 2:23 PM / in a year

BRIEF-Myriad will seek Japanese regulatory approval for Bracanalysis CDX

Nov 7 (Reuters) - Myriad Genetics Inc

* Myriad will seek Japanese regulatory approval for Bracanalysis Cdx

* Myriad genetics inc - will submit Bracanalysis CDX test for approval by Japan’s pharmaceuticals and medical devices agency Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below